Mark J. Litton
- Immunology top 1%
- Immunotherapy and Immune Responses 6
- Immune Cell Function and Interaction 4
- Immune Response and Inflammation 2
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research 2
- Obstetrics and Gynecology top 5%
- Virology top 10%
- Parasitology top 10%
-
- Cancer Immunotherapy and Biomarkers 3
- CAR-T cell therapy research 2
-
- Streptococcal Infections and Treatments 2
-
- Monoclonal and Polyclonal Antibodies Research 2
Mark J. Litton
12 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Immunology 1.6k
- Immunology and Allergy 121
- Obstetrics and Gynecology 114
- Virology 55
- Parasitology 72
Countries citing papers authored by Mark J. Litton
This map shows the geographic impact of Mark J. Litton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Litton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Litton more than expected).
Fields of papers citing papers by Mark J. Litton
This network shows the impact of papers produced by Mark J. Litton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Litton. The network helps show where Mark J. Litton may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark J. Litton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 29 | |
| 2 | Tumor therapy with an antibody-targeted superantigen generates a dichotomy between local and systemic immune responses. | 1997 | 30 |
| 3 | 1997 | 75 | |
| 4 | 1996 | 285 | |
| 5 | 1996 | 6 | |
| 6 | 1996 | 60 | |
| 7 | 1996 | 28 | |
| 8 | 1995 | 59 | |
| 9 | Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells.breakdown → | 1995 | 1281 |
| 10 | 1994 | 55 | |
| 11 | 1994 | 37 | |
| 12 | Concomitant in vivo production of 19 different cytokines in human tonsils. | 1994 | 123 |
About Mark J. Litton
Mark J. Litton is a scholar working on Immunology, Immunology and Allergy, Oncology, Parasitology and Reproductive Medicine, having authored 12 papers that have together received 2.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (6 papers), Immune Cell Function and Interaction (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), CAR-T cell therapy research (2 papers), Immune Response and Inflammation (2 papers), Streptococcal Infections and Treatments (2 papers), Cell Adhesion Molecules Research (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Immunology (1.6k citations), Immunology and Allergy (121 citations), Obstetrics and Gynecology (114 citations), Virology (55 citations) and Parasitology (72 citations). Mark J. Litton has collaborated with scholars based in Sweden, United States and Belgium. Frequent co-authors include Anne O’Garra, Maria Wysocka, Chyi‐Song Hsieh, Paulo Vieira, Giorgio Trinchieri, S E Macatonia, Kenneth M. Murphy, Nancy Hosken, Janice Culpepper and J S Abrams. Their work appears in journals such as Acta Oto-Laryngologica, British Journal of Cancer, The Journal of Immunology, Immunotechnology and Clinical & Experimental Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.